Chemeotherapy, Coronavirus, Immunotherapy, Quality of Life, Treatment Mofidied
Conditions
Brief summary
To limit Corona virus dissemination on its territory, France applied strict confinement from March 16th to May 11th. Scientific societies recommended treatment modifications and remote consultations that were applied. This study evaluates the clinical impact of these care adaptation on patients under treatment for a digestive tumor. A special focus is made on quality of life and psycho-social impact of treatment modifications on patients diagnosed with metastatic colorectal cancer and metastatic pancreatic cancer.
Interventions
OTHERPsycho-Social Questionnaire
Patients, after enrollmenet in the study, receive a paper questionnaire during the month following COVID19 related confinement and all the material to send it back to the institution. They receive the same questionnaire 3 months later with all the material to send it back to the institution. The intervention is the same for all patients wether their treatment was modified or not.
Sponsors
Poitiers University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Histologically proven digestive tumor * Ongoing treatment from March,1st and April 30th
Exclusion criteria
* Patient refusal for enrollment in the study * Patient not recognised legally competent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival of patients with metastatic colorectal cancer or metastatic pancreatic cancer | 6 months |
Countries
France
Outcome results
None listed